■ MATERIAL WEAKNESS WATCH
Nasdaq · CIK 0001840877

COCH Envoy Medical, Inc.

D
40 / 100
Material weaknesses
3
Restatements
0
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
0
Deductions
60
Remediation credit
0

Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.

Disclosures, in the company's words

  • Material weakness10-Q · filed 2026-11-05 · Item 4source filing ↗
    “The Company has yet to fully design and maintain effective controls over certain information technology general controls for information systems that are relevant to the preparation of its unaudited condensed consolidated financial statements, including ineffective controls around user access and segregation of duties.”
  • Material weakness10-Q · filed 2026-11-05 · Item 4source filing ↗
    “The Company has yet to fully design, document and maintain formal accounting policies, procedures and controls over significant accounts and disclosures to achieve complete, accurate and timely financial accounting, reporting and disclosures, including segregation of duties and adequate controls related to the preparation, posting, modification and review of journal entries, and the accounting treatment of complex transactions, including fair value measurements under U.S. GAAP.”
  • Material weakness10-Q · filed 2026-11-05 · Item 4source filing ↗
    “The Company s management has not yet fully implemented a formal risk assessment process that addresses risks relevant to financial reporting objectives, including cybersecurity and fraud risks.”
  • Controls not effective10-Q · filed 2026-11-05 · Item 4source filing ↗
    “our Chief Executive Officer and Chief Accounting Officer and Vice President of Finance concluded that, as of such date, our disclosure controls and procedures were not effective due to the existence of the material weaknesses in the Company s internal control over financial reporting described below.”

Filings read

Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.